By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mirna Therapeutics, Inc. 

2150 Woodward Street
Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-901-0900 Fax: 512-681-5201


Company News
Micro Cancer Fighter Mirna Files for $81 Million IPO 8/25/2015 6:32:30 AM
Mirna Therapeutics Rakes in $41.8 Million in Series D As Lonestar Bio Booms 4/30/2015 6:55:12 AM
Marina Biotech, Inc. (MRNA) Reports That Partner Mirna Therapeutics, Inc. Presented Interim Phase 1 Data On Its First-in-Class microRNA-34 Mimic 11/20/2014 11:41:30 AM
Mirna Therapeutics, Inc. Presents Interim Phase 1 Data On First-In-Class Microrna-34 Mimic, MRX34, At The 26th EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics 11/20/2014 8:57:50 AM
Mirna Therapeutics, Inc. Appoints Lawrence M. Alleva To Its Board Of Directors 9/15/2014 10:16:39 AM
Marina Biotech, Inc. (MRNA) Announces That Licensee Mirna Therapeutics, Inc. Enrolls First Patient In Hematologic Malignancy Cohort Of On-Going Trial 6/12/2014 10:26:12 AM
Mirna Therapeutics, Inc.Announces First Patient Enrolled In Hematological Malignancy Cohort Of Its Phase 1 Clinical Trial 6/10/2014 10:00:16 AM
Mirna Therapeutics, Inc. Announces Interim Phase 1 Safety Data On Lead Product Candidate MRX34 at American Association for Cancer Research Annual Meeting 4/9/2014 6:29:12 AM
Mirna Therapeutics, Inc. Appoints Casi Deyoung As Chief Business Officer 3/19/2014 7:19:58 AM
Mirna Therapeutics, Inc. Announces Scientific Publication That Suggests Enhanced Potency Of Lead Therapeutic Microrna In Combination With FDA Approved Lung Cancer Dru 2/18/2014 9:54:40 AM